Trial Profile
Single Dose Crossover Comparative Bioavailability Study of Eslicarbazepine Acetate 400mg, 600mg and 800mg Tablets Clinical Trial Formulation (CTF) Versus the To-be-marketed Formulation (TBM) in Healthy Male and Female
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Dec 2014
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Migraine; Neuropathic pain; Partial epilepsies; Postherpetic neuralgia
- Focus Pharmacokinetics
- Sponsors Bial
- 07 Nov 2014 New trial record